Recent Advances in 3D Bioprinted Tumor Microenvironment

被引：0
作者：
Jinseung Bae
Seogkyu Han
Sungsu Park
机构：
[1] Sungkyunkwan University,School of Mechanical Engineering
来源：
BioChip Journal | 2020年 / 14卷
关键词：
Tumors; 3D Bioprinting; Microenvironment; Metastasis; Method;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tumors in vivo exist in a microenvironment, so-called tumor microenvironment (TME), which includes peripheral blood vessels, immune cells, fibroblasts, signalling molecules and extracellular matrix. In recent years, considerable efforts have been focused on developing bioprinting methods because 3D bioprinting can better recapitulate TMEs by accurately printing different types of TME cells in spatially localised regions. In this review, we first introduce TME and 3D bioprinting methods and later discuss bioprinted TMEs as tumor equivalents for understanding tumor biology as well as testing drug efficacy.
引用
收藏
页码：137 / 147
页数：10
相关论文
共 434 条
[1]  
Dzobo K(2019)Recent trends in decellularized extracellular matrix bioinks for 3D printing: An updated review Int. J. Mol. Sci. 20 4628-785
[2]  
Motaung KSCM(2014)3D bioprinting of tissues and organs Nat. Biotechnol. 32 773-1721
[3]  
Adesida A(2016)Bioprinting the cancer microenvironment ACS Biomater. Sci. Eng. 2 1710-513
[4]  
Murphy SV(2015)Bioprinting for cancer research Trends Biotechnol. 33 504-207
[5]  
Atala A(2017)Advanced biomaterials and micro-engineering technologies to recapitulate the stepwise process of cancer metastasis Biomaterials 133 176-183
[6]  
Zhang YS(2016)Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs J. Enzyme Inhib. Med. Chem. 31 177-497
[7]  
Duchamp M(2011)Cancer associated fibro-blasts: the dark side of the coin Am. J. Cancer Res. 1 482-172
[8]  
Oklu R(2009)TGF-β-induced epithelial to mesenchymal transition Cell Res. 19 156-92
[9]  
Ellisen LW(2019)Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy J. Hematol. Oncol. 12 86-1284
[10]  
Langer R(2019)Tumor neovascularization and developments in therapeutics Cancers 11 316-17
12345678910